52
https://pubmed.ncbi.nlm.nih.gov/38116607
The prevalence of antiphospholipid antibodies in subjects with biopsy-proven renal thrombotic microangiopathy is estimated to be around 24.4%.
“Prevalence of Antiphospholipid Antibodies in Renal Thrombotic Microangiopathy: A Study”
